Strikingly, we found that while moderate reduction of Gata2 expression increased competitiveness in CebpaDM AML both in vivo and in vitro, leukemia cells remain critically dependent on residual GATA2 function. This evidence concerns the gene GATA2 and acute myeloid leukemia.